The 21st Century Cures Act--Will It Take Us Back in Time?

N Engl J Med. 2015 Jun 25;372(26):2473-5. doi: 10.1056/NEJMp1506964. Epub 2015 Jun 3.

Authors

Jerry Avorn¹, Aaron S Kesselheim

Affiliation

¹ From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.

PMID: 26039522
DOI: 10.1056/NEJMp1506964

No abstract available

MeSH terms

Biomarkers
Device Approval / legislation & jurisprudence*
Drug Approval / legislation & jurisprudence*
Drug Discovery / economics*
Drug Discovery / legislation & jurisprudence
Government Regulation*
Humans
National Institutes of Health (U.S.)
Research Support as Topic / legislation & jurisprudence
United States
United States Food and Drug Administration / legislation & jurisprudence*

Substances

Biomarkers